Abstract:Lung cancer is the first malignant and morbidity tumor worldwide, and non-small cell lung cancer (NSCLC) is the main type. Majority of patients with lung cancer died because of metastasis and recurrence of tumors. In order to prolong patients’ survival rate, early diagnosis and development of more effective drug treatment become the main research direction to clinical doctors and scientists. However, previous research of our team found that expression of p70S6K protein was significantly suppressed after silencing Raf1 expression, and overexpression of p70S6K had worse survival prognosis in patients with NSCLC. But, whether p70S6K is regulated by Raf1 is still not clear. Therefore, our aim of this research is to explore the cross talk between Raf1 and p70S6K in NSCLC. The construct of the lentivirus RNA vector targeting Raf1 and p70S6K were verified by sequencing. Co-infection systems were composed with shRaf1 and p70S6K overexpression lentiviral vectors. Western blot was used to tested p70S6K and Raf1 protein expression level of each cell line. Status of proliferation, apoptosis and cycle were observed in vitro. Ability of tumorigenesis of NSCLC cells were assessed using nude mouse models in vivo. We obtained the stable cell clones of silenced Raf1 gene expression, overexpression of p70S6K and co-expression of Raf1 and p70S6K. In vitro, the function of cell proliferation, apoptosis and cycle of co-infected groups were located between shRaf1 groups and OE-p70S6K groups. The weight and volume of transplanted tumors of co-infected groups were obviously higher than shRaf1 groups and lower than OE-p70S6K groups. Results of Ki-67 and TUNEL examination were consistent with experiment in vitro and in vivo. The figures below only show the results in vivo. Targeted silence Raf1 expression joint p70S6K overexpression had antagonism effect to the biological behavior of NSCLC. Raf1 might affect the biological behavior of NSCLC according to p70S6K.

Research Progress of Raf-1 Protein Kinase in Signal Transduction.

Studies on the Biological Function of Raf Kinase Inhibitor Protein(rkip)

Decoding The Full Picture Of Raf1 Function Based On Its Interacting Proteins

Second nature: Biological functions of the Raf-1 “kinase”

Progresses in the structure and biological function of Raf kinase inhibitory protein

Regulation role of Raf kinase inhibitory protein to mitogen-activated protein kinase signaling pathway

Research Progress of Receptor Tyrosine Protein Kinase

Signaling from RAS to RAF: The Molecules and Their Mechanisms

Raf kinases in signal transduction and interaction with translation machinery

Advances in the Research of Raf Kinase Inhibitors and Drug Resistance Mechanisms

Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism

Revealing A-Raf Functions Through Its Interactome

Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling.

Rencent Advances in the Function of R-Ras

Dynamics of Ras Complexes Observed in Living Cells.

Regulation of RAF protein kinases in ERK signalling

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

Structural Basis for RKIP Binding with Its Substrate Raf1 Kinase

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

Design, Synthesis, and Biological Evaluation of New B-RafV600E Kinase Inhibitors

PUB120 Research on the Roles and Molecular Mechanisms of Raf1/p70S6K Signaling Pathway in Non-Small Cell Lung Cancer